Vitamin D Dosage Calculator
Calculate your recommended daily vitamin D intake in IU based on your current blood level, target level, body weight, and sun exposure.
Results
Visualization
How It Works
Vitamin D is a secosteroid hormone synthesized in skin via UVB exposure (290-315 nm) and obtained from food. Status is assessed by serum 25-hydroxyvitamin D [25(OH)D]. NAM/IOM defines adequacy as 20 ng/mL (50 nmol/L); the Endocrine Society sets 30 ng/mL as the threshold for sufficiency in at-risk populations. Adult RDA is 600 IU through age 70 and 800 IU after 70. Tolerable Upper Intake Level (UL) is 4,000 IU/day. This calculator estimates a daily IU target by combining the deficit between current and target serum levels, body weight, and a sun-exposure offset.
The Formula
Variables
- Deficit — Target 25(OH)D minus current 25(OH)D in ng/mL
- Weight — Body weight in kg (adipose tissue sequesters vitamin D, raising the dose needed in obesity)
- 1.5 — Empirical IU-per-(ng/mL x kg) factor derived from Heaney 2003 and Veugelers 2014 dose-response data
- Sun_IU — Approximate cutaneous synthesis (~100 IU/min for fair skin at solar noon, capped at 60 minutes)
Worked Example
Northern-latitude winter scenario, 70 kg adult with serum 25(OH)D of 20 ng/mL targeting 50 ng/mL with 15 minutes of midday window light: Deficit = 30, Sun_IU = 1,500, Base = 30 x 70 x 1.5 = 3,150 IU, Recommended = 3,150 - 1,500 = 1,650 IU/day. After 12 weeks at this dose, expected serum 25(OH)D rise is ~12-20 ng/mL based on Heaney's 100 IU per ng/mL per liter rule (Heaney et al., AJCN 2003). Retest at 3 months to confirm response. Obese adults (BMI 30+) typically need 2-3x this dose to reach the same serum level due to volumetric distribution into adipose (Drincic et al., Obesity 2012).
Practical Tips
- D3 (cholecalciferol) raises 25(OH)D roughly 1.7x more efficiently than D2 (ergocalciferol) per Tripkovic 2012 meta-analysis — choose D3 unless on a vegan protocol that requires lichen-sourced D3.
- Take with the largest fatty meal of the day. Mulligan & Licata 2010 showed a 32% absorption advantage versus low-fat meals.
- Fitzpatrick skin types V-VI need 3-6x longer UVB exposure than type II to produce equivalent vitamin D (Clemens et al., Lancet 1982). Latitude above 35 degrees produces no cutaneous D from November to February regardless of sun time.
- Magnesium is a cofactor for the 25-hydroxylase and 1-alpha-hydroxylase enzymes that activate vitamin D. Hypomagnesemia blunts response to D supplementation (Uwitonze & Razzaque, JAOA 2018).
- Anticonvulsants (phenytoin, phenobarbital), glucocorticoids, and orlistat lower 25(OH)D — patients on these may need 2-4x the standard dose.
- Pair D3 with vitamin K2 (MK-7, 90-180 mcg) when supplementing 2,000+ IU long-term to direct calcium to bone rather than vasculature (Knapen 2015 Thrombosis Haemost).
Frequently Asked Questions
Why is my 25(OH)D still low after taking 2,000 IU/day for months?
Three common causes: BMI 30+ (vitamin D distributes into adipose, raising effective dose 2-3x), magnesium deficiency (cofactor for hepatic 25-hydroxylase), or malabsorption (celiac, gastric bypass, IBD). A 12-week trial of 5,000 IU/day plus 300 mg magnesium glycinate, then retest. If still under 30 ng/mL, request a 1,25-dihydroxyvitamin D test to rule out activation defects.
How much D does sun exposure actually produce?
Holick's classic estimate: a fair-skinned adult in a swimsuit at solar noon in summer produces ~10,000-25,000 IU in 15-30 minutes (one minimal erythemal dose). Realistic urban conditions with face and forearms exposed give ~1,000-3,000 IU per 20-minute session. Above 35 degrees latitude (Atlanta, Memphis), zenith angle blocks UVB November through February — winter D status depends on diet or supplementation.
What target level should I aim for?
NAM/IOM endorses 20 ng/mL as adequate for bone health based on PTH suppression and calcium absorption data. The Endocrine Society recommends 30 ng/mL minimum, with 40-60 ng/mL as the optimal range for high-risk groups (osteoporosis, malabsorption, dark skin at high latitude). Above 100 ng/mL increases hypercalcemia risk; toxicity typically requires sustained levels over 150 ng/mL.
Should I supplement vitamin D2 or D3?
D3 (cholecalciferol) raises serum 25(OH)D ~1.7x more efficiently than D2 (ergocalciferol) at equivalent doses (Tripkovic et al., AJCN 2012 meta-analysis of 10 RCTs). D2 is plant-derived and the only prescription form (Drisdol 50,000 IU). For routine supplementation D3 is superior. Vegans should use lichen-sourced D3 if available.
How fast can I correct severe deficiency under 12 ng/mL?
Standard protocol: 50,000 IU D2 or D3 weekly for 6-8 weeks, then a maintenance dose of 1,500-2,000 IU/day. Pereira-Santos 2015 review showed mean serum rise of 33 ng/mL over 8 weeks with this loading regimen. Retest at week 12 — not earlier — because serum 25(OH)D has a 2-3 week half-life and equilibrates slowly.
Does vitamin D toxicity actually occur from supplements?
Documented but rare. Case reports involve sustained intake above 50,000 IU/day, manufacturing errors (one report involved 2,000,000 IU/serving), or genetic CYP24A1 mutations. Symptoms: hypercalcemia, polyuria, kidney stones, nausea. Vieth's review (AJCN 1999) found no toxicity at sustained 10,000 IU/day. The 4,000 IU UL is a precautionary margin, not a toxicity threshold.
Should I take K2 with my D3?
Mechanistically plausible — K2 activates osteocalcin (drives calcium into bone) and matrix Gla protein (blocks vascular calcification). Knapen 2015 showed 180 mcg/day MK-7 reduced arterial stiffness in postmenopausal women over 3 years. Strongest case: long-term D3 supplementation above 2,000 IU/day plus calcium intake at or above RDA. Combination is low-risk; benefit is modest in healthy users.
Is sublingual or liquid D3 better absorbed than capsules?
No clinically meaningful difference in healthy adults. Grossmann & Tangpricha 2010 trial showed equivalent serum response between oil-based capsules and oral spray. Sublingual marketing claims rest on theoretical mucosal absorption, but vitamin D is fat-soluble and primarily absorbed via the small intestine. Liquid drops can help patients with swallowing difficulty or pediatric dosing.
Sources
- NIH Office of Dietary Supplements — Vitamin D Health Professional Fact Sheet
- Holick et al., Endocrine Society Clinical Practice Guideline (J Clin Endocrinol Metab 2011)
- NAM/IOM Dietary Reference Intakes for Calcium and Vitamin D (2011)
- Tripkovic et al., Comparison of D2 vs D3 (AJCN 2012)
- Uwitonze & Razzaque, Magnesium and Vitamin D Activation (JAOA 2018)